![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Acandis Gains CE Mark for Accero Stent
Acandis Gains CE Mark for Accero Stent
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Acandis_Logo.gif?t=1540519144&width=430)
German devicemaker Acandis has received a CE Mark for its Accero stent, a smooth-surfaced implant for treating intracranial aneurysms that is now available for sale in Europe.
Accero is a self-expanding braided stent that is designed to exhibit reliable coil retention. It can be delivered through double lumen balloon guide catheters and 0.0165 to 0.0170” microcatheters.
The stent’s titanium oxide/oxynitride protective film is designed with high oxygen and nitrogen intensities to improve vessel healing.
Upcoming Events
-
21Oct